SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-004652
Filing Date
2014-09-15
Accepted
2014-09-15 16:45:39
Documents
11
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT oxbt_10q.htm 10-Q 792430
2 CERTIFICATION oxbt_ex311.htm EX-31.1 15313
3 CERTIFICATION oxbt_ex312.htm EX-31.2 16053
4 CERTIFICATION oxbt_ex321.htm EX-32.1 9627
5 CERTIFICATION oxbt_ex322.htm EX-32.2 10825
  Complete submission text file 0001354488-14-004652.txt   3958592

Data Files

Seq Description Document Type Size
6 oxbt-20140731.xml EX-101.INS 522020
7 oxbt-20140731.xsd EX-101.SCH 38177
8 oxbt-20140731_cal.xml EX-101.CAL 41462
9 oxbt-20140731_def.xml EX-101.DEF 39145
10 oxbt-20140731_lab.xml EX-101.LAB 240215
11 oxbt-20140731_pre.xml EX-101.PRE 158255
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-34600 | Film No.: 141103629
SIC: 8731 Services-Commercial Physical & Biological Research